3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 1
2
Phase NA
1
Phase 3
1
Status
Completed
3
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
580
Neoplasms
488
Prostatic Neoplasms
311
Lung Neoplasms
236
Colorectal Neoplasms
199
Motor Activity
131
Carcinoma, Non-Small-Cell Lung
117
Uterine Cervical Neoplasms
112
Brain Neoplasms
110
Pancreatic Neoplasms
109
Head and Neck Neoplasms
106
Stomach Neoplasms
99
Carcinoma, Hepatocellular
98
Rectal Neoplasms
97
Ovarian Neoplasms
86
Colonic Neoplasms
86
Neoplasm Metastasis
67
Multiple Myeloma
65
Esophageal Neoplasms
65
Hematologic Neoplasms
62
Urinary Bladder Neoplasms
60
Glioblastoma
59
Melanoma
58
Sarcoma
57
Precursor Cell Lymphoblastic Leukemia-Lymphoma
57
Endometrial Neoplasms
56
Glioma
53
Lymphoma
50
Leukemia, Myeloid, Acute
48
Gastrointestinal Neoplasms
48
Interventions
regorafenib
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Recruiting
×
Histiocytoma, Malignant Fibrous
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled